Paper19684847
Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.
Güler S and 8 others. Arch Drug Inf, 2009. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results. Papers, record 19684847. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19684847
- Disease
- type 2 diabetes mellitus613 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01536600 | Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes | Results |
Source ClinicalTrials.gov
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9742976 | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. | Lancet | 1998 | https://conductscience.org/library/papers/9742976 | PubMed |
| 2 | 11815505 | Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). | Diabetes Care | 2002 | https://conductscience.org/library/papers/11815505 | PubMed |
| 3 | 11009049 | Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart. | Eur J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/11009049 | PubMed |
| 4 | 12027927 | Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients. | Diabet Med | 2002 | https://conductscience.org/library/papers/12027927 | PubMed |
| 5 | 16398567 | Premixed insulin analogues for the treatment of diabetes mellitus. | Drugs | 2006 | https://conductscience.org/library/papers/16398567 | PubMed |
| 6 | 15495054 | Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus. | Cochrane Database Syst Rev | 2004 | https://conductscience.org/library/papers/15495054 | PubMed |
| 7 | 10359389 | Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. | JAMA | 1999 | https://conductscience.org/library/papers/10359389 | PubMed |
| 8 | 16519037 | Postprandial glucose regulation: new data and new implications. | Clin Ther | 2005 | https://conductscience.org/library/papers/16519037 | PubMed |
| 9 | 16759299 | Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. | Diabet Med | 2006 | https://conductscience.org/library/papers/16759299 | PubMed |
| 10 | 14749149 | Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy. | Clin Ther | 2003 | https://conductscience.org/library/papers/14749149 | PubMed |
| 11 | 15677776 | Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. | Diabetes Care | 2005 | https://conductscience.org/library/papers/15677776 | PubMed |
| 12 | 3124685 | Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study. | Ann Intern Med | 1988 | https://conductscience.org/library/papers/3124685 | PubMed |
| 13 | 9831300 | The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus. | Exp Clin Endocrinol Diabetes | 1998 | https://conductscience.org/library/papers/9831300 | PubMed |
| 14 | 12502617 | Implications of the United kingdom prospective diabetes study. | Diabetes Care | 2003 | https://conductscience.org/library/papers/12502617 | PubMed |
| 15 | 14617231 | Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes. | Diabetes Obes Metab | 2003 | https://conductscience.org/library/papers/14617231 | PubMed |
| 16 | 18269636 | Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. | Diabetes Obes Metab | 2008 | https://conductscience.org/library/papers/18269636 | PubMed |
| 17 | 16873813 | Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. | Diabetes Care | 2006 | https://conductscience.org/library/papers/16873813 | PubMed |
| 18 | 16367881 | Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes. | Diabetes Obes Metab | 2006 | https://conductscience.org/library/papers/16367881 | PubMed |
| 19 | 14583174 | Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin. | J Diabetes Complications | 2003 | https://conductscience.org/library/papers/14583174 | PubMed |
| 20 | 15668084 | Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes. | Eur J Intern Med | 2004 | https://conductscience.org/library/papers/15668084 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26458540 | Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis. | BMC Endocr Disord | 2015 | https://conductscience.org/library/papers/26458540 | PubMed |
| 22818015 | Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings. | Drugs | 2012 | https://conductscience.org/library/papers/22818015 | PubMed |
| 22047050 | The impact of initiating biphasic human insulin 30 therapy in type 2 diabetes patients after failure of oral antidiabetes drugs. | Diabetes Technol Ther | 2012 | https://conductscience.org/library/papers/22047050 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| SI | 6476 | PubTator's text mining | https://conductscience.org/library/genes/6476 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19684847
GET https://conductscience.org/api/papers/v1/19684847/authors